Stay updated with breaking news from Newtyn management. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Visionary Wealth Advisors raised its position in PAR Technology Co. (NYSE:PAR – Free Report) by 2.8% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 317,938 shares of the software maker’s stock after buying an additional 8,635 shares during the period. PAR Technology accounts […] ....
StockNews.com lowered shares of Theravance Biopharma (NASDAQ:TBPH – Free Report) from a buy rating to a hold rating in a report issued on Tuesday morning. Several other equities analysts have also commented on TBPH. HC Wainwright reaffirmed a buy rating and issued a $20.00 price objective on shares of Theravance Biopharma in a research report […] ....
Adverum Biotechnologies, Inc. (NASDAQ:ADVM – Get Free Report) has received an average rating of “Buy” from the four brokerages that are currently covering the firm, Marketbeat Ratings reports. Four analysts have rated the stock with a buy rating. The average 1-year target price among brokerages that have issued a report on the stock in the […] ....
StockNews.com upgraded shares of Theravance Biopharma (NASDAQ:TBPH – Free Report) from a hold rating to a buy rating in a research report report published on Monday. Several other equities research analysts also recently commented on the stock. BTIG Research began coverage on shares of Theravance Biopharma in a research report on Friday, April 12th. They […] ....
SVB Leerink reissued their market perform rating on shares of Bolt Biotherapeutics (NASDAQ:BOLT – Free Report) in a research report released on Wednesday morning, Benzinga reports. SVB Leerink currently has a $1.00 price target on the stock, down from their previous price target of $3.00. Several other research analysts have also recently commented on BOLT. […] ....